View More View Less
  • 1 Szegedi Tudományegyetem, Általános Orvostudományi Kar, Klinikai Központ Pszichiátriai Klinika Szeged Kálvária sgt. 57. 6722
  • 2 Szegedi Tudományegyetem, Általános Orvostudományi Kar, Klinikai Központ Bőrgyógyászati és Allergológiai Klinika Szeged
  • 3 Semmelweis Egyetem, Általános Orvostudományi Kar Kútvölgyi Klinikai Tömb, Klinikai és Kutatási Mentálhigiénés Osztály Budapest
  • 4 Országos Pszichiátriai és Adiktológiai Intézet Budapest
  • 5 MTA–SE Neuropszichofarmakológiai Kutatócsoport Budapest

A pikkelysömör kialakulásában és progressziójában a betegek és az orvosok jelentős hányada a stresszt tartja az egyik legfontosabb rizikótényezőnek. Mivel a stresszor és hatásai is egyaránt szubjektumfüggőek és így nehezen mérhetőek, sokáig csupán kevés, a stressznek a betegség kialakulásában játszott szerepét vizsgáló tanulmány készült. Az elmúlt években azonban egyre több nívós, objektív mérésekkel alátámasztott vizsgálat született, amelyek új, értékes adatokkal szolgáltak a háttérben zajló patofiziológiai folyamatok megértéséhez. A szerzők a szakirodalomban fellelhető stresszexpozíciót és -percepciót befolyásoló pszichológiai (alexithymia, személyiség, hangulat) és a stresszválaszt szabályozó biológiai (kortizol-, adrenalinszintek, neurogén gyulladás) tényezőket elemző vizsgálatokat integratív, pszichoszomatikus szemlélettel tekintik át, és bemutatják, hogy az eddig főleg csak tapasztalati szinten bizonyított kapcsolatot egyre több modern, magas színvonalú kutatási eredmény igazolja. Ismerve a stresszcsökkentő pszichofarmakológiai és pszichoterápiás intervenciók sikerességét a pikkelysömör kezelésében és a betegek életminőségének javításában, a szerzők bíznak abban, hogy tanulmányuk hozzájárul a pszichoszomatikus szemlélet szélesebb körű elterjedéséhez a mindennapi bőrgyógyászati gyakorlatban. Orv. Hetil., 2014, 155(24), 939–948.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Gyulai, R., Kemény, L.: The immunology of psoriasis: from basic research to the bedside. [A psoriasis immunológiája: alapkutatástól a betegágyig.] Orv. Hetil., 2006, 147(46), 2213–2220. [Hungarian]

  • Griffiths, C. E., Barker, J. N.: Pathogenesis and clinical features of psoriasis. Lancet, 2007, 370(9583), 263–271.

  • Gupta, M. A., Gupta, A. K., Kirkby, S., et al.: A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients. Gen. Hosp. Psychiatry, 1989, 11(3), 166–173.

  • Zachariae, R., Zachariae, H., Blomqvist, K., et al.: Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J. Eur. Acad. Dermatol. Venereol., 2004, 18(1), 27–36.

  • Kabat-Zinn, J., Wheeler, E., Light, T., et al.: Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom. Med., 1998, 60(5), 625–632.

  • Tausk, F., Whitmore, S. E.: A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother. Psychosom., 1999, 68(4), 221–225.

  • Lazaroff, I., Shimshoni, R.: Effects of medical resonance therapy music on patients with psoriasis and neurodermatitis – a pilot study. Integr. Physiol. Behav. Sci., 2000, 35(3), 189–198.

  • Hunter, H. J., Griffiths, C. E., Kleyn, C. E.: Does psychosocial stress play a role in the exacerbation of psoriasis? Br. J. Dermatol., 2013, 169(5), 965–974.

  • DeWeerdt, S.: Psychodermatology: An emotional response. Nature, 2012, 492(7429), S62–S63.

  • Verhoeven, E. W., Kraaimaat, F. W., Jong, E. M., et al.: Effect of daily stressors on psoriasis: a prospective study. J. Invest. Dermatol., 2009, 129(8), 2075–2077.

  • Picardi, A., Pasquini, P., Cattaruzza, M. S., et al.: Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J. Psychosom. Res., 2003, 55(3), 189–196.

  • Al’Abadie, M. S., Kent, G. G., Gawkrodger, D. J.: The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br. J. Dermatol., 1994, 130(2), 199–203.

  • Lazarus, R. S.: Emotion and adaptation. Oxford University Press, London, 1991.

  • Willemsen, R., Roseeuw, D., Vanderlinden, J.: Alexithymia and dermatology: the state of the art. Int. J. Dermatol., 2008, 47(9), 903–910.

  • Evers, A. W., Verhoeven, E. W., Kraaimaat, F. W., et al.: How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br. J. Dermatol., 2010, 163(5), 986–991.

  • Fava, G. A., Perini, G. I., Santonastaso, P., et al.: Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br. J. Med. Psychol., 1980, 53(3), 277–282.

  • Rubino, I. A., Sonnino, A., Stefanato, C. M., et al.: Separation-individuation, aggression and alexithymia in psoriasis. Acta Derm. Venereol. Suppl. (Stockh.), 1989, 146, 87–90.

  • Allegranti, I., Gon, T., Magaton-Rizzi, G., et al.: Prevalence of alexithymic characteristics in psoriatic patients. Acta Derm. Venereol. Suppl. (Stockh.), 1994, 186, 146–147.

  • Fortune, D. G., Richards, H. L., Griffiths, C. E., et al.: Targeting cognitive-behaviour therapy to patients’ implicit model of psoriasis: results from a patient preference controlled trial. Br. J. Clin. Psychol., 2004, 43(Pt 1), 65–82.

  • Richards, H. L., Fortune, D. G., Griffiths, C. E., et al.: Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J. Psychosom. Res., 2005, 58(1), 89–96.

  • Picardi, A., Mazzotti, E., Gaetano, P., et al.: Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics, 2005, 46(6), 556–564.

  • Consoli, S. M., Rolhion, S., Martin, C., et al.: Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology, 2006, 212(2), 128–136.

  • Schneider, G., Hockmann, J., Ständer, S., et al.: Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study. Br. J. Dermatol., 2006, 154(1), 61–66.

  • Conrad, R., Geiser, F., Haidl, G., et al.: Relationship between anger and pruritus perception in patients with chronic idiopathic urticaria and psoriasis. J. Eur. Acad. Dermatol. Venereol., 2008, 22(9), 1062–1069.

  • Taylor, G. J., Bagby, R. M., Parker, J. D.: The alexithymia construct. A potential paradigm for psychosomatic medicine. Psychosomatics, 1991, 32(2), 153–164.

  • Näätänen, P., Ryynänen, A., Keltikangas-Järvinen, L.: The influence of alexithymic characteristics on the self-perception and facial expression of a physiological stress state. Psychother. Psychosom., 1999, 68(5), 252–262.

  • Ormel, J., Wohlfarth, T.: How neuroticism, long-term difficulties, and life situation change influence psychological distress: a longitudinal model. J. Pers. Soc. Psychol., 1991, 60(5), 744–755.

  • Rihmer, Z., Akiskal, K. K., Rihmer, A., et al.: Current research on affective temperaments. Curr. Opin. Psychiatry, 2010, 23(1), 12–18.

  • Eory, A., Gonda, X., Torzsa, P., et al.: Affective temperaments: from neurobiological roots to clinical application. [Affektív temperamentumok: a neurobiológiai alapoktól a klinikai alkalmazásig.] Orv. Hetil., 2011, 152(47), 1879–1886. [Hungarian]

  • Mroczek, D. K., Almeida, D. M.: The effect of daily stress, personality, and age on daily negative affect. J. Pers., 2004, 72(2), 355–378.

  • Bahmer, J. A., Kuhl, J., Bahmer, F. A.: How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria? Acta Derm. Venereol., 2007, 87(4), 317–324.

  • Kiliç, A., Güleç, M. Y., Gül, U., et al.: Temperament and character profile of patients with psoriasis. J. Eur. Acad. Dermatol. Venereol., 2008, 22(5), 537–542.

  • Kotrulja, L., Tadinac, M., Jokić-Begić, N. A., et al.: A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients. Acta Derm. Venereol., 2010, 90(3), 251–256.

  • Ak, M., Haciomeroglu, B., Turan, Y., et al.: Temperament and character properties of male psoriasis patients. J. Health Psychol., 2012, 17(5), 774–781.

  • Remröd, C., Sjöström, K., Svensson, A.: Psychological differences between early- and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. Br. J. Dermatol., 2013, 169(2), 344–350.

  • Litaiem, N., Youssef, S., Jabeur, K., et al.: Affective temperament profile in psoriasis patients in Tunisia using TEMPS-A. J. Affect. Disord., 2013, 151(1), 321–324.

  • Hayes, J., Koo, J.: Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol. Ther., 2010, 23(2), 174–180.

  • Miller, A. H., Maletic, V., Raison, C. L.: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry, 2009, 65(9), 732–741.

  • Rieder, E., Tausk, F.: Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int. J. Dermatol., 2012, 51(1), 12–26.

  • Kurd, S. K., Troxel, A. B., Crits-Christoph, P., et al.: The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch. Dermatol., 2010, 146(8), 891–895.

  • Gupta, M. A., Gupta, A. K.: Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br. J. Dermatol., 1998, 139(5), 846–850.

  • Picardi, A., Mazzotti, E., Pasquini, P.: Prevalence and correlates of suicidal ideation among patients with skin disease. J. Am. Acad. Dermatol., 2006, 54(3), 420–426.

  • Farber, E. M., Nickoloff, B. J., Recht, B., et al.: Stress, symmetry, and psoriasis: possible role of neuropeptides. J. Am. Acad. Dermatol., 1986, 14(2 Pt 1), 305–311.

  • Sapolsky, R. M., Romero, L. M., Munck, A. U.: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev., 2000, 21(1), 55–89.

  • Heller, M. M., Lee, E. S., Koo, J. Y.: Stress as an influencing factor in psoriasis. Skin Therapy Lett., 2011, 16(5), 1–4.

  • Sanders, V. M., Straub, R. H.: Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun., 2002, 16(4), 290–332.

  • Sternberg, E. M.: Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol., 2006, 6(4), 318–328.

  • Elenkov, I. J., Wilder, R. L., Bakalov, V. K., et al.: IL-12, TNF-alpha, and hormonal changes during late pregnancy and early post partum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab., 2001, 86(10), 4933–4938.

  • Chikanza, I. C., Petrou, P., Kingsley, G., et al.: Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum., 1992, 35(11), 1281–1288.

  • Buske-Kirschbaum, A., Geiben, A., Höllig, H., et al.: Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J. Clin. Endocrinol. Metab., 2002, 87(9), 4245–4251.

  • Griep, E. N., Boersma, J. W., Lentjes, E. G., et al.: Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J. Rheumatol., 1998, 25(7), 1374–1381.

  • Heim, C., Ehlert, U., Hanker, J. P., et al.: Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom. Med., 1998, 60(3), 309–318.

  • Arnetz, B. B., Fjellner, B., Eneroth, P., et al.: Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom. Med., 1985, 47(6), 528–541.

  • Buske-Kirschbaum, A., Ebrecht, M., Kern, S., et al.: Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris) – do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)? Psychoneuroendocrinology, 2006, 31(4), 439–446.

  • Thaller, V., Vrkljan, M., Hotujac, L., et al.: The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis. Coll. Antropol., 1999, 23(2), 611–619.

  • Richards, H. L., Ray, D. W., Kirby, B., et al.: Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br. J. Dermatol., 2005, 153(6), 1114–1120.

  • Amatya, B., El-Nour, H., Holst, M., et al.: Expression of tachykinins and their receptors in plaque psoriasis with pruritus. Br. J. Dermatol., 2011, 164(5), 1023–1029.

  • Remröd, C., Lonne-Rahm, S., Nordlind, K.: Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch. Dermatol. Res., 2007, 299(2), 85–91.

  • Mastrolonardo, M., Alicino, D., Zefferino, R., et al.: Effect of psychological stress on salivary interleukin-1beta in psoriasis. Arch. Med. Res., 2007, 38(2), 206–211.

  • Weigl, B. A.: The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int. J. Dermatol., 2000, 39(9), 678–688.

  • Szegedi, A., Aleksza, M., Gonda, A., et al.: Elevated rate of Thelper1 (TH1) lymphocytes and serum IFN-gamma levels in psoriatic patients. Immunol. Lett., 2003, 86(3), 277–280.

  • Karanikas, E., Harsoulis, F., Giouzepas, I., et al.: Neuroendocrine stimulatory tests of hypothalamus-pituitary-adrenal axis in psoriasis and correlative implications with psychopathological and immune parameters. J. Dermatol., 2009, 36(1), 35–44.

  • Schmid-Ott, G., Jacobs, R., Jäger, B., et al.: Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. A preliminary study. Psychother. Psychosom., 1998, 67(1), 37–42.

  • Ionescu, G., Kiehl, R.: Increased plasma norepinephrine in psoriasis. Acta Derm. Venereol., 1991, 71(2), 169–170.

  • Ito, N., Ito, T., Kromminga, A., et al.: Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal (HPA) axis and synthesize cortisol. FASEB J., 2005, 19(10), 1332–1334.

  • Christophers, E., Metzler, G., Röcken, M.: Bimodal immune activation in psoriasis. Br. J. Dermatol., 2014, 170(1), 59–65.

  • Peters, E. M., Liezmann, C., Klapp, B. F., et al.: The neuroimmune connection interferes with tissue regeneration and chronic inflammatory disease in the skin. Ann. N. Y. Acad. Sci., 2012, 1262, 118–126.

  • Harvima, I. T., Nilsson, G., Suttle, M. M., et al.: Is there a role for mast cells in psoriasis? Arch. Dermatol. Res., 2008, 300(9), 461–478.

  • Leslie, M.: Mast cells show their might. Science, 2007, 317(5838), 614–616.

  • Saraceno, R., Kleyn, C. E., Terenghi, G., et al.: The role of neuropeptides in psoriasis. Br. J. Dermatol., 2006, 155(5), 876–882.

  • Reich, A., Orda, A., Wiśnicka, B., et al.: Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Exp. Dermatol., 2007, 16(5), 421–428.

  • Peters, E. M., Kuhlmei, A., Tobin, D. J., et al.: Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav. Immun., 2005, 19(3), 252–262.

  • Singh, L. K., Pang, X., Alexacos, N., et al.: Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav. Immun., 1999, 13(3), 225–239.

  • Erin, N., Ersoy, Y., Ercan, F., et al.: NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats. Clin. Exp. Dermatol., 2004, 29(6), 644–648.

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Nov 2020 0 2 4
Dec 2020 0 8 16
Jan 2021 0 3 8
Feb 2021 0 16 27
Mar 2021 0 10 11
Apr 2021 0 1 1
May 2021 0 0 0